Skip to Content
Merck
  • Hypercalcemia Leads to Delayed Corneal Wound Healing in Ovariectomized Rats.

Hypercalcemia Leads to Delayed Corneal Wound Healing in Ovariectomized Rats.

Biological & pharmaceutical bulletin (2015-07-03)
Noriaki Nagai, Fumihiko Ogata, Naohito Kawasaki, Yoshimasa Ito, Yoshinori Funakami, Norio Okamoto, Yoshikazu Shimomura
ABSTRACT

Hypercalcemia is often observed in postmenopausal women as well as in patients with primary hyperparathyroidism or malignant tumors. In this study, we investigated the relationship between calcium ion (Ca(2+)) levels in lacrimal fluid and the rate of corneal wound healing in hypercalcemia using ovariectomized (OVX) rat debrided corneal epithelium. We also determined the effects of Ca(2+) levels on cell adhesion, proliferation and viability in a human cornea epithelial cell line (HCE-T). The calcium content in bones of OVX rats decreased after ovariectomy. Moreover, the Ca(2+) content in the blood of OVX rats was increased 1 month after ovariectomy, and decreased. The Ca(2+) content in the lacrimal fluid of OVX rats was also increased after ovariectomy, and then decreased similarly as in blood. Corneal wound healing in OVX rats was delayed in comparison with Sham rats (control rats), and a close relationship was observed between the Ca(2+) levels in lacrimal fluid and the rate of corneal wound healing in Sham and OVX rats (y=-0.7863x+8.785, R=0.78, n=25). In addition, an enhancement in Ca(2+) levels caused a decrease in the viability in HCE-T cells. It is possible that enhanced Ca(2+) levels in lacrimal fluid may cause a decrease in the viability of corneal epithelial cells, resulting in a delay in corneal wound healing. These findings provide significant information that can be used to design further studies aimed at reducing corneal damage of patients with hypercalcemia.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Fluorescein, for fluorescence, free acid